BioSpace News Archive

Drug Development

MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies

MEI Pharma, Inc. announced updated data from the ongoing Phase 1b study of investigational ME-401, a selective oral inhibitor of PI3K delta.

October 3, 2019
·
8 min read
Business

ResMed to Report First Quarter Fiscal 2020 Earnings on October 24, 2019

ResMed announced it plans to release financial and operational results for the first quarter of fiscal year 2020 on Thursday, October 24, 2019, after the New York Stock Exchange closes.

October 3, 2019
·
1 min read
Job Trends

Aural Analytics Speech Platform Powers Clinical Trial Showing Potential Early Treatment Effect for ALS Patients Treated with Investigational Therapy

Data Powered by The Aural Analytics Speech Analytics Platform Technology Will be Presented at The 18th Annual Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) Meeting

October 3, 2019
·
5 min read
Deals

Zoetis Declares Fourth Quarter 2019 Dividend

The Board of Directors of Zoetis Inc. has declared a fourth quarter 2019 dividend payable to holders of the company’s common stock of $0.164 per share.

October 3, 2019
·
2 min read
Deals

CVS Health Corporation Announces Quarterly Dividend payable on November 4, 2019

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

October 3, 2019
·
1 min read
Business

LivaNova to Host Conference Call for Third Quarter 2019 Results

LivaNova PLC, a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2019 results on Wednesday, October 30, 2019 at 12 p.m. London time.

October 3, 2019
·
3 min read
Enyo Pharma Announces Move to New Corporate Headquarters

ENYO Pharma, a private clinical stage biotechnology company developing innovative drug candidates, today announced the relocation of the Company’s headquarters to the 8th Arrondissement in Lyon.

October 3, 2019
·
2 min read
Business

NanoView Biosciences and Alfatest Enter into Distribution Agreement

NanoView Biosciences, Inc., and Alfatest announced an exclusive distribution agreement for NanoView’s ExoView™ platform in Italy.

October 3, 2019
·
2 min read
Lilly Announces Voluntary Delisting from Euronext Paris

Eli Lilly and Company (NYSE: LLY) announced today that it has requested the delisting of its shares (ISIN US5324571083) (“Lilly Shares”) from Euronext Paris due to the very low trading volume, costs and administrative requirements related to its secondary listing on Euronext Paris

October 3, 2019
·
5 min read
BioCapital

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)

Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, announced the adjustment of an options award that was previously approved in accordance with Nasdaq Listing Rule 5635(c)(4).

October 3, 2019
·
3 min read